279 related articles for article (PubMed ID: 26768570)
21. Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee.
Mupapa K; Massamba M; Kibadi K; Kuvula K; Bwaka A; Kipasa M; Colebunders R; Muyembe-Tamfum JJ
J Infect Dis; 1999 Feb; 179 Suppl 1():S18-23. PubMed ID: 9988160
[TBL] [Abstract][Full Text] [Related]
22. Randomized controlled trials in the West African Ebola virus outbreak.
Upshur R; Fuller J
Clin Trials; 2016 Feb; 13(1):10-2. PubMed ID: 26768558
[No Abstract] [Full Text] [Related]
23. Ebola virus convalescent blood products: where we are now and where we may need to go.
Burnouf T; Seghatchian J
Transfus Apher Sci; 2014 Oct; 51(2):120-5. PubMed ID: 25457751
[TBL] [Abstract][Full Text] [Related]
24. A meta-analysis of clinical studies conducted during the West Africa Ebola virus disease outbreak confirms the need for randomized control groups.
Dodd LE; Follmann D; Proschan M; Wang J; Malvy D; van Griensven J; Ciglenecki I; Horby PW; Ansumana R; Jiang JF; Davey RT; Lane HC; Gouel-Cheron A
Sci Transl Med; 2019 Nov; 11(520):. PubMed ID: 31776287
[TBL] [Abstract][Full Text] [Related]
25. Organization of patient care during the Ebola hemorrhagic fever epidemic in Kikwit, Democratic Republic of the Congo, 1995.
Guimard Y; Bwaka MA; Colebunders R; Calain P; Massamba M; De Roo A; Mupapa KD; Kibadi K; Kuvula KJ; Ndaberey DE; Katwiki KR; Mapanda BB; Nkuku OB; Fleerackers Y; Van den Enden E; Kipasa MA
J Infect Dis; 1999 Feb; 179 Suppl 1():S268-73. PubMed ID: 9988194
[TBL] [Abstract][Full Text] [Related]
26. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit.
Rowe AK; Bertolli J; Khan AS; Mukunu R; Muyembe-Tamfum JJ; Bressler D; Williams AJ; Peters CJ; Rodriguez L; Feldmann H; Nichol ST; Rollin PE; Ksiazek TG
J Infect Dis; 1999 Feb; 179 Suppl 1():S28-35. PubMed ID: 9988162
[TBL] [Abstract][Full Text] [Related]
27. Apheresis for collection of Ebola convalescent plasma in Liberia.
Brown JF; Rowe K; Zacharias P; van Hasselt J; Dye JM; Wohl DA; Fischer WA; Cunningham CK; Thielman NM; Hoover DL
J Clin Apher; 2017 Jun; 32(3):175-181. PubMed ID: 27393614
[TBL] [Abstract][Full Text] [Related]
28. [Marburg and Ebola hemorrhagic fevers--pathogens, epidemiology and therapy].
Stock I
Med Monatsschr Pharm; 2014 Sep; 37(9):324-30; quiz 331-2. PubMed ID: 25282746
[TBL] [Abstract][Full Text] [Related]
29. Early and repeated use of plasma for the management of Ebola patients: Reflection around a case.
Dufour-Gaume F; Delaune D; Martinaud C; Sailliol A
Transfus Clin Biol; 2017 Feb; 24(1):5-8. PubMed ID: 27640108
[TBL] [Abstract][Full Text] [Related]
30. Passive Immunotherapy: Assessment of Convalescent Serum Against Ebola Virus Makona Infection in Nonhuman Primates.
Mire CE; Geisbert JB; Agans KN; Thi EP; Lee AC; Fenton KA; Geisbert TW
J Infect Dis; 2016 Oct; 214(suppl 3):S367-S374. PubMed ID: 27571900
[TBL] [Abstract][Full Text] [Related]
31. Selecting the right tool for the job.
Caplan AL; Plunkett C; Levin B
Am J Bioeth; 2015; 15(4):4-10. PubMed ID: 25856591
[TBL] [Abstract][Full Text] [Related]
32. Evaluating large-scale blood transfusion therapy for the current Ebola epidemic in Liberia.
Gutfraind A; Meyers LA
J Infect Dis; 2015 Apr; 211(8):1262-7. PubMed ID: 25635118
[TBL] [Abstract][Full Text] [Related]
33. Ebola virus disease outbreak: what's going on.
Giraldi G; Marsella LT
Ann Ig; 2015; 27(1):82-6. PubMed ID: 25748509
[TBL] [Abstract][Full Text] [Related]
34. The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States.
Kraft CS; Hewlett AL; Koepsell S; Winkler AM; Kratochvil CJ; Larson L; Varkey JB; Mehta AK; Lyon GM; Friedman-Moraco RJ; Marconi VC; Hill CE; Sullivan JN; Johnson DW; Lisco SJ; Mulligan MJ; Uyeki TM; McElroy AK; Sealy T; Campbell S; Spiropoulou C; Ströher U; Crozier I; Sacra R; Connor MJ; Sueblinvong V; Franch HA; Smith PW; Ribner BS;
Clin Infect Dis; 2015 Aug; 61(4):496-502. PubMed ID: 25904375
[TBL] [Abstract][Full Text] [Related]
35. Clinical presentation and management of severe Ebola virus disease.
West TE; von Saint André-von Arnim A
Ann Am Thorac Soc; 2014 Nov; 11(9):1341-50. PubMed ID: 25369317
[TBL] [Abstract][Full Text] [Related]
36. A response adaptive randomization platform trial for efficient evaluation of Ebola virus treatments: A model for pandemic response.
Berry SM; Petzold EA; Dull P; Thielman NM; Cunningham CK; Corey GR; McClain MT; Hoover DL; Russell J; Griffiss JM; Woods CW
Clin Trials; 2016 Feb; 13(1):22-30. PubMed ID: 26768569
[TBL] [Abstract][Full Text] [Related]
37. Treatment of ebola virus disease.
Kilgore PE; Grabenstein JD; Salim AM; Rybak M
Pharmacotherapy; 2015 Jan; 35(1):43-53. PubMed ID: 25630412
[TBL] [Abstract][Full Text] [Related]
38. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
39. Notes from the Field: Baseline Assessment of the Use of Ebola Rapid Diagnostic Tests--Forécariah, Guinea, October-November 2015.
Huang JY; Louis FJ; Dixon MG; Sefu M; Kightlinger L; Martel LD; Jayaraman GC; Gueye AS
MMWR Morb Mortal Wkly Rep; 2016 Apr; 65(12):328-9. PubMed ID: 27030992
[TBL] [Abstract][Full Text] [Related]
40. [The register of activity at the Ebola treatment center in Forecariah (Guinea) from april 23 to june 5, 2015: analysis and thoughts].
Gaüzère BA; Ouellet I; Nottebrock D; Nied JC; Beya-Kadiebwe B; Camara AK; Camara D; Camara ML; Camara M; Soumah A; Tounkara MK; Monteil V; Camara A; Bauffe F; Camara A; Camara IB; Sissoko D; Simon B; Jaspard M; Tran-Minh T; L'Hériteau F
Bull Soc Pathol Exot; 2016 Oct; 109(4):272-280. PubMed ID: 27459988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
